Highthink Med Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
881
- Latest Deal Type
-
IPO
- (Cancelled)
- Investors
-
8
Highthink Med General Information
Description
Provider of contract research organization services intended to provide phase I-IV clinical research for medical companies. The company provides phase I-IV clinical research and related services for pharmaceutical companies, medical device companies and new drug research institutions, enabling medical companies to obtain contract clinical research services.
Contact Information
Website
www.highthinkmed.comCorporate Office
- Room 03, 9th Floor, Building 1-11, Floor 101, Building 1, District 3
- No. 186 South Fourth Ring West Road, Fengtai District
- Beijing, 100161
- China
Corporate Office
- Room 03, 9th Floor, Building 1-11, Floor 101, Building 1, District 3
- No. 186 South Fourth Ring West Road, Fengtai District
- Beijing, 100161
- China
Highthink Med Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. IPO | 21-Apr-2026 | Cancelled | Generating Revenue | |||
| 12. Later Stage VC | 18-May-2023 | Completed | Profitable | |||
| 11. IPO | 16-Mar-2023 | Completed | Profitable | |||
| 10. Secondary Transaction - Private | 22-Jul-2022 | Completed | Profitable | |||
| 9. Later Stage VC | 21-Dec-2021 | Completed | Profitable | |||
| 8. Later Stage VC | 25-Oct-2021 | Completed | Profitable | |||
| 7. Secondary Transaction - Private | 30-Mar-2021 | Completed | Profitable | |||
| 6. Later Stage VC (Series B) | 03-Dec-2020 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 07-Sep-2020 | $434K | $6.32M | Completed | Generating Revenue | |
| 4. Secondary Transaction - Private | 30-Dec-2019 | $6.32M | Completed | Generating Revenue |
Highthink Med Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | 2,190,800 | $6.6 | $6.6 | 1x | $6.6 | 3.02% | ||
| Ordinary Shares | 1,464,000 | $3.95 | $3.95 | 1x | $3.95 | 2.02% |
Highthink Med Signals
Highthink Med Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CITIC Securities Investment Company | Corporate Venture Capital | Minority | ||
| Central SOEs Industrial Investment Fund for Poor Area | Government | Minority | ||
| Renhe Capital | Asset Manager | Minority | ||
| CICC Capital | PE/Buyout | Minority | ||
| Roton Capital | Venture Capital | Minority |
Highthink Med Investments (2)
Highthink Med’s most recent deal was a Later Stage VC with Zheyuan Technology. The deal was made on 15-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zheyuan Technology | 15-Jun-2022 | Later Stage VC | Decision/Risk Analysis | ||
| Meizer Pharma | 19-Jan-2021 | Early Stage VC | Drug Discovery |
Highthink Med FAQs
-
When was Highthink Med founded?
Highthink Med was founded in 2006.
-
Where is Highthink Med headquartered?
Highthink Med is headquartered in Beijing, China.
-
What is the size of Highthink Med?
Highthink Med has 881 total employees.
-
What industry is Highthink Med in?
Highthink Med’s primary industry is BPO/Outsource Services.
-
Is Highthink Med a private or public company?
Highthink Med is a Private company.
-
What is Highthink Med’s current revenue?
The current revenue for Highthink Med is .
-
How much funding has Highthink Med raised over time?
Highthink Med has raised $44M.
-
Who are Highthink Med’s investors?
CITIC Securities Investment Company, Central SOEs Industrial Investment Fund for Poor Area, Renhe Capital, CICC Capital, and Roton Capital are 5 of 8 investors who have invested in Highthink Med.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process